37330271|t|Jujuboside A ameliorates cognitive deficiency in delirium through promoting hippocampal E4BP4 in mice.
37330271|a|OBJECTIVE: Delirium (acute brain syndrome) is a common and serious neuropsychiatric disorder characterized by an acute decline in cognitive function. However, there is no effective treatment clinically. Here we investigated the potential effect of jujuboside A (JuA, a natural triterpenoid saponin) on cognitive impairment in delirium. METHODS: Delirium models of mice were established by injecting lipopolysaccharide (LPS) plus midazolam and implementing a jet lag protocol. Novel object recognition test and Y maze test were used to evaluate the effects of JuA on delirium-associated cognitive impairment. The mRNA and protein levels of relevant clock factors and inflammatory factors were measured by qPCR and Western blotting. Hippocampal Iba1+ intensity was determined by immunofluorescence staining. KEY FINDINGS: JuA ameliorated delirium (particularly delirium-associated cognitive impairment) in mice, which was proved by the behavioural tests, including a preference for new objects, an increase of spontaneous alternation and improvement of locomotor activity. Furthermore, JuA inhibited the expression of ERK1/2, p-p65, TNFalpha and IL-1beta in hippocampus, and repressed microglial activation in delirious mice. This was attributed to the increased expression of E4BP4 (a negative regulator of ERK1/2 cascade and microglial activation). Moreover, loss of E4bp4 in mice abrogated the effects of JuA on delirium as well as on ERK1/2 cascade and microglial activation in the hippocampus of delirious mice. Additionally, JuA treatment increased the expression of E4BP4 and decreased the expression of p-p65, TNFalpha and IL-1beta in LPS-stimulated BV2 cells, supporting a protective effect of JuA on delirium. CONCLUSIONS: JuA protects against delirium-associated cognitive impairment through promoting hippocampal E4BP4 in mice. Our findings are of great significance to the drug development of JuA against delirium and related disorders.
37330271	0	12	Jujuboside A	Chemical	MESH:C087808
37330271	25	45	cognitive deficiency	Disease	MESH:D003072
37330271	49	57	delirium	Disease	MESH:D003693
37330271	88	93	E4BP4	Gene	18030
37330271	97	101	mice	Species	10090
37330271	114	122	Delirium	Disease	MESH:D003693
37330271	124	144	acute brain syndrome	Disease	MESH:D001930
37330271	170	195	neuropsychiatric disorder	Disease	MESH:D001523
37330271	222	251	decline in cognitive function	Disease	MESH:D003072
37330271	351	363	jujuboside A	Chemical	MESH:C087808
37330271	365	368	JuA	Chemical	MESH:C087808
37330271	380	392	triterpenoid	Chemical	MESH:D014315
37330271	393	400	saponin	Chemical	MESH:D012503
37330271	405	425	cognitive impairment	Disease	MESH:D003072
37330271	429	437	delirium	Disease	MESH:D003693
37330271	448	456	Delirium	Disease	MESH:D003693
37330271	467	471	mice	Species	10090
37330271	502	520	lipopolysaccharide	Chemical	MESH:D008070
37330271	522	525	LPS	Chemical	MESH:D008070
37330271	532	541	midazolam	Chemical	MESH:D008874
37330271	662	665	JuA	Chemical	MESH:C087808
37330271	669	677	delirium	Disease	MESH:D003693
37330271	689	709	cognitive impairment	Disease	MESH:D003072
37330271	769	781	inflammatory	Disease	MESH:D007249
37330271	846	850	Iba1	Gene	114737
37330271	923	926	JuA	Chemical	MESH:C087808
37330271	939	947	delirium	Disease	MESH:D003693
37330271	962	970	delirium	Disease	MESH:D003693
37330271	982	1002	cognitive impairment	Disease	MESH:D003072
37330271	1007	1011	mice	Species	10090
37330271	1187	1190	JuA	Chemical	MESH:C087808
37330271	1219	1225	ERK1/2	Gene	26417;26413
37330271	1229	1232	p65	Gene	19697
37330271	1234	1242	TNFalpha	Gene	21926
37330271	1247	1255	IL-1beta	Gene	16176
37330271	1321	1325	mice	Species	10090
37330271	1378	1383	E4BP4	Gene	18030
37330271	1409	1415	ERK1/2	Gene	26417;26413
37330271	1470	1475	E4bp4	Gene	18030
37330271	1479	1483	mice	Species	10090
37330271	1509	1512	JuA	Chemical	MESH:C087808
37330271	1516	1524	delirium	Disease	MESH:D003693
37330271	1539	1545	ERK1/2	Gene	26417;26413
37330271	1612	1616	mice	Species	10090
37330271	1632	1635	JuA	Chemical	MESH:C087808
37330271	1674	1679	E4BP4	Gene	18030
37330271	1714	1717	p65	Gene	19697
37330271	1719	1727	TNFalpha	Gene	21926
37330271	1732	1740	IL-1beta	Gene	16176
37330271	1744	1747	LPS	Chemical	MESH:D008070
37330271	1759	1762	BV2	CellLine	CVCL:0182
37330271	1804	1807	JuA	Chemical	MESH:C087808
37330271	1811	1819	delirium	Disease	MESH:D003693
37330271	1834	1837	JuA	Chemical	MESH:C087808
37330271	1855	1863	delirium	Disease	MESH:D003693
37330271	1875	1895	cognitive impairment	Disease	MESH:D003072
37330271	1926	1931	E4BP4	Gene	18030
37330271	1935	1939	mice	Species	10090
37330271	2007	2010	JuA	Chemical	MESH:C087808
37330271	2019	2027	delirium	Disease	MESH:D003693
37330271	Positive_Correlation	MESH:D008070	MESH:D003693
37330271	Negative_Correlation	MESH:C087808	MESH:D003693
37330271	Positive_Correlation	MESH:D008874	MESH:D003693
37330271	Negative_Correlation	MESH:C087808	19697
37330271	Negative_Correlation	MESH:C087808	26417
37330271	Negative_Correlation	MESH:C087808	MESH:D003072
37330271	Negative_Correlation	MESH:C087808	26413
37330271	Positive_Correlation	MESH:C087808	18030
37330271	Negative_Correlation	MESH:C087808	16176
37330271	Association	MESH:D003693	18030
37330271	Negative_Correlation	MESH:C087808	MESH:D008070
37330271	Negative_Correlation	MESH:C087808	21926
37330271	Association	MESH:D003072	18030

